Affiliated Hospital (Suzhou First People's Hospital)

Suzhou

1 studies enrolling now · 1 studies all time

What they study most

Ovarian Cancer

Studies at this site

• Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) — Recruiting now